Literature DB >> 28081455

Correlates of vitamin D in psychotic disorders: A comprehensive systematic review.

James Adamson1, John Lally2, Fiona Gaughran3, Amir Krivoy3, Lauren Allen4, Brendon Stubbs3.   

Abstract

People with psychosis have high prevalence of low vitamin D levels but the correlates and relevance of this deficiency are unclear. A systematic search of major databases from inception to 03/2016 was undertaken investigating correlates of vitamin D in people with psychosis. Data was summarised with a best evidence synthesis. Across 23 included studies (n=1770 psychosis, n=8171 controls) a mean difference in vitamin D levels between both groups of -11.14ng/ml±0.59 was found. 53 unique correlations between vitamin D and outcomes in people with psychosis were identified. The evidence base was broadly equivocal although season of blood sampling (67% of studies found a positive correlation with warmer seasons) and parathyroid hormone (100% of studies found a negative correlation) were associated with vitamin D levels. The most commonly non-correlated variables were: BMI (83% found no correlation), age (73%), gender (86%), smoking (100%), duration of illness (100%) and general assessment of functioning score (100%). In conclusion, whilst many unique correlates have been investigated, there is weak and inconclusive evidence regarding the consistency and meaning of the correlates of vitamin D levels in people with psychosis. Future longitudinal studies should consider the correlates of vitamin D in people with psychosis.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  25-OHD; 25-hydroxyvitamin D; Hypovitaminosis D; Psychosis; Schizophrenia; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 28081455     DOI: 10.1016/j.psychres.2016.12.052

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

1.  Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.

Authors:  Lirong Wang; Jian Ying; Peihao Fan; Elise A Weamer; Mary Ann A DeMichele-Sweet; Oscar L Lopez; Julia K Kofler; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-27       Impact factor: 4.105

2.  Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia.

Authors:  G Fond; M Faugere; C Faget-Agius; M Cermolacce; R Richieri; L Boyer; C Lançon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-08-04       Impact factor: 5.270

3.  Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis.

Authors:  Joseph Firth; Rebekah Carney; Brendon Stubbs; Scott B Teasdale; Davy Vancampfort; Philip B Ward; Michael Berk; Jerome Sarris
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

4.  Vitamin D Deficiency/Insufficiency among Inpatients with Depressive Symptoms.

Authors:  Young Sup Woo; Sangha Kim; Jong-Hyun Jeong; Young-Eun Jung; Moon-Doo Kim; Won-Myong Bahk
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-02-28       Impact factor: 2.582

Review 5.  Pathogenesis and management of Brugada syndrome in schizophrenia: A scoping review.

Authors:  Anuj Rastogi; Dylan Viani-Walsh; Shareef Akbari; Nicholas Gall; Fiona Gaughran; John Lally
Journal:  Gen Hosp Psychiatry       Date:  2020-10-06       Impact factor: 3.238

Review 6.  A Review of the Relationship of the Cerebrospinal Fluid Changes During the Dysregulation of Parathyroid Hormone With Psychiatric or Neurological Manifestations.

Authors:  Ifrah Kaleem; Josh Alexander; Mohamed Hisbulla; Vishmita Kannichamy; Vinayak Mishra; Amit Banerjee; Arohi B Gandhi; Safeera Khan
Journal:  Cureus       Date:  2021-01-13

7.  Vitamin D Deficiency and Risk Factors Related to Acute Psychiatric Relapses in Patients with Severe Mental Disorders: A Preliminary Study.

Authors:  Michele Fabrazzo; Salvatore Agnese; Salvatore Cipolla; Matteo Di Vincenzo; Emiliana Mancuso; Antonio Volpicelli; Francesco Perris; Gaia Sampogna; Francesco Catapano; Andrea Fiorillo; Mario Luciano
Journal:  Brain Sci       Date:  2022-07-24

Review 8.  Vitamin D in the time of the coronavirus (COVID-19) pandemic - a clinical review from a public health and public mental health perspective.

Authors:  Ursula Werneke; Fiona Gaughran; David M Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2021-07-09

9.  The psychotropic effect of vitamin D supplementation on schizophrenia symptoms.

Authors:  Aras Neriman; Yilmaz Hakan; Ucuncu Ozge
Journal:  BMC Psychiatry       Date:  2021-06-15       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.